A Multicenter Study on the Impact of Gender, Age, and Dual Diagnosis on Substance Consumption and Mental Health Status in Outpatients Treated for Substance Use Disorders During COVID-19 Lockdown

• Published in: Journal of dual diagnosis 2022-04, Vol.18 (2), p.71-80
• Main Authors: Daigre, Constanza, Grau-López, Lara, Palma-Alvarez, Raúl F, Perea-Ortueta, Marta, Sorribes-Puertas, Marta, Serrano-Pérez, Pedro, Quesada, Marta, Segura, Lidia, Coronado, Marta, Ramos-Quiroga, Josep Antoni, Colom, Joan
• Format: Article
• Language: English
• Subjects: Adult; Age; Cocaine; Communicable Disease Control; Coronaviruses; COVID-19; Diagnosis, Dual (Psychiatry); Drug use; Female; Gender; Health Status; Humans; Male; Mental health; Middle Aged; Outpatients; Shelter in place; Substance-Related Disorders - complications; Substance-Related Disorders - epidemiology; Substance-Related Disorders - therapy
• ISSN: 1550-4263; 1550-4271
• DOI: 10.1080/15504263.2022.2051110

COVID-19 and lockdown measures impacted mental health globally and had a particular impact on patients with substance use disorders (SUD). However, the impact of gender, age, and dual diagnosis on consumption patterns and mental health during COVID-19 lockdown among patients with SUD has not been analyzed in depth. Therefore, this study aimed to examine substance use and mental health status during COVID-19 lockdown considering gender, age, and previous dual diagnosis in patients with SUD treated in different outpatient addiction clinics in Catalonia. Thirteen clinics participated and 588 patients were enrolled in the study, of whom 70.7% were men and 29.3% were women. The mean age was 48 ± 11.3 years, and 63.2% had dual diagnoses. Men reported significantly more frequent alcohol and cocaine consumption during lockdown, while women experienced more anxiety and depressive symptoms. Younger patients more frequently reported consuming cocaine and cannabis, breaking the lockdown rule, worsened family relationships, and reduced incomes. Older patients more frequently reported maintaining abstinence. Previous dual diagnosis was more often associated with benzodiazepine use disorder, less active working during lockdown, and more anxiety and depressive symptoms than not having previous dual diagnosis. Both new psychiatric symptoms and general worsening of existing symptoms were frequent during the lockdown. Differences based on the gender, age, and dual diagnosis of outpatients treated for substance use disorders should be considered in the planning of protection measures such as home confinement.